Pegylated Interferon/Ribavirin dual therapy in patients with chronic Hepatitis C: results of 323 cases
Journal Title: Journal of Microbiology and Infectious Diseases - Year 2015, Vol 5, Issue 4
Abstract
Objective: The combination of pegylated interferon-α (PEG-IFN) and ribavirin has become a mainstay in the treatment of chronic hepatitis C (CHC). We aimed to evaluate the efficacy of this treatment in patients with CHC, while considering new approaches. Methods: A total of 323 patients with CHC underwent PEG-IFN and ribavirin combination treatment from the 3 centers (2 in Ordu and 1 in Samsun provinces) in Middle Black Sea region between the years of 2003-2013. Results: Of the patients, 208 (67%) were female and had a mean age 54 ± 10 years (median: 54; 19-70). Genotyping was performed in 163 patients, and 161 patients (98.8%) revealed genotype 1. Sustained virologic response (SVR) and the end of treatment response rates were 58.3% and 75.6%, respectively. In patients with rapid virological response, the SVR rate was 85.1%, whereas in patients with a HCV RNA level less than 800,000 IU/ml, the SVR rate was 71.2%. The SVR rates were found to be higher in patients who developed hypothyroidism, which was statistically significant (p = 0.03). The most frequent side effect was anemia, followed by thrombocytopenia, fatigue, and loss of appetite. Conclusion: Presently, PEG-IFN/ribavirin is still an option in the treatment of certain patient populations even after the consideration of newer treatment methods. J Microbiol Infect Dis 2015;5(4): 151-155 Key words: Pegylated interferon, ribavirin, therapy, hepatitis C
Authors and Affiliations
Aynur Atilla, Emel Duyar, Fatih Bostancı, S. Sırrı Kılıç
Keywords
Related Articles
- EP ID EP90364
- DOI 10.5799/ahinjs.02.2015.04.0196
- Views 172
- Downloads 0
Pegylated Interferon/Ribavirin dual therapy in patients with chronic Hepatitis C: results of 323 cases
Objective: The combination of pegylated interferon-α (PEG-IFN) and ribavirin has become a mainstay in the treatment of chronic hepatitis C (CHC). We aimed to evaluate the efficacy of this treatment in patients with CHC,...
Expansion of plasmid mediated blaACT-2 among Pseudomonas aeruginosa associated with hospital infection and its transcriptional response under cephalosporin stress
Objectives: Organisms harboring multiple plasmid mediated β-lactamases are major concerns in nosocomial infections. Among these plasmid mediated β-lactamases, ACT (EBC family) is a clinically important enzyme capable of...
Retropharyngeal cellulitis complicated by cervical spondylodiscitis: A case report
Secondary to pharyngeal trauma such as endotracheal intubation, endoscopy and after foreign body ingestion, or removal may develop retropharyngeal cellulitis in adults. These infections occur mainly in children between 1...
An Unusual Masquerader Residing in the Lungs
Parasitic infections of the lungs are almost always rare as the number of causative parasites is limited. There is an equal balance between protozoans and helminths causing lung infections. Most of the times, these infec...
Effect of temperature on storage of ethionamide during susceptibility testing
Objective: Ethionamide being thermolabile in nature, effect of temperature on the drug and its stability in liquid and solid media during susceptibility testing procedures was assessed to understand the inconsistency in...